Chinese Academy of Medical Sciences: all 237 studies

Page 2 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic CancerStatus unknownNCT03815461Phase 2
• HFSRT With Concurrent TMZ for Large BMsStatus unknownNCT03778541Phase 3
• Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast CancerStatus unknownNCT03735082Phase 2
• GR1405 Injection in Patients With Advanced Solid Tumor or LymphomaStatus unknownNCT03731390Phase 1
• Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal CarcinomaStatus unknownNCT03639467Phase 1/2
• Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLCStatus unknownNCT03636685Phase 1/2
• Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell LymphomaStatus unknownNCT03630731Phase 2
• SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell CancerStatus unknownNCT03603756Phase 2
• Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCCCompletedNCT03572829Phase 2
• New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal CarcinomaStatus unknownNCT03558035Phase 2
• Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal CancerStatus unknownNCT03545711Phase 1/2
• Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast CancerCompletedNCT03535961Phase 2
• Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric CancerStatus unknownNCT03427684Phase 1/2
• Factors Influencing Cancer Patients Participation in Clinical Trials in China.Status unknownNCT03412344
• Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular LymphomaStatus unknownNCT03410004Phase 2
• Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal CancerStatus unknownNCT03381352Phase 2
• FSRT Combined With TMZ for Large BMs: a PSM StudyCompletedNCT03338075
• Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03Status unknownNCT03328234Phase 3
• Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving SurgeryCompletedNCT03320421Not applicable
• Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02Status unknownNCT03308552Phase 3
• Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01CompletedNCT03298204
• The Phase IVd of Inactivated Enterovirus 71 VaccineStatus unknownNCT03296410Phase 4
• Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical CancerCompletedNCT03243825Not applicable
• The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell)Status unknownNCT03240744Phase 4
• A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine TumorStatus unknownNCT03204032Phase 2
• A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine TumorStatus unknownNCT03204019Phase 2
• A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid CancerStatus unknownNCT03199677Phase 2
• A Hospital Based Survey on Lung Cancer Related-pain in Northern ChinaStatus unknownNCT03189277
• A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway PatientsStatus unknownNCT03108391Not applicable
• Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03083613Phase 2
• A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced BreastStatus unknownNCT03047889
• Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by ChemotherapyStatus unknownNCT03039062
• Tomotherapy for Refractory Brain MetastasesStatus unknownNCT03027544Not applicable
• The Phase IVa of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17)Status unknownNCT02999828Phase 4
• Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)Status unknownNCT02995187Phase 2
• Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit ElderlyCompletedNCT02992886Phase 2
• Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01CompletedNCT02979691Phase 2/3
• Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR MutationStatus unknownNCT02961270Phase 2
• High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLCStatus unknownNCT02960607Phase 2
• The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and AdolescentsCompletedNCT02953730Phase 4
• S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast CancerStatus unknownNCT02947061Phase 2
• Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast CancerStatus unknownNCT02934828Phase 2
• Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal CarcinomaStatus unknownNCT02858206Phase 2
• Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer PatientsStatus unknownNCT02829008Phase 2
• The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With ChemotherapyStatus unknownNCT02771756Not applicable
• Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast CancerStatus unknownNCT02768415Phase 2
• Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer PatientsStatus unknownNCT02765373
• Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal CancerCompletedNCT02725424Phase 2
• Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal CancerStatus unknownNCT02688023Phase 2
• Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung CancerStatus unknownNCT02675088Not applicable
• Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain MetastasesCompletedNCT02654106Phase 2
• A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.Status unknownNCT02648841Phase 3
• Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer PatientsStatus unknownNCT02646735Phase 2
• Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast CancerStatus unknownNCT02595138Phase 3
• Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeStatus unknownNCT02560441Phase 2
• Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical ResectionStatus unknownNCT02537158Not applicable
• Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) CancerStatus unknownNCT02512380Phase 3
• Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver MetastasesStatus unknownNCT02510378Phase 2
• A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid TumorsCompletedNCT02496949Phase 1
• Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT02461043Phase 3
• Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic ApproachStatus unknownNCT02448979Phase 3
• Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic EsophagectomyStatus unknownNCT02448966
• Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node InvolvementStatus unknownNCT02448953Not applicable
• Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell CarcinomaCompletedNCT02446574Phase 1/2
• Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal CarcinomaCompletedNCT02429622Phase 1/2
• GDP in Frontline Chemotherapy for Patients With PTCL-NOSStatus unknownNCT02404571Phase 2
• Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular CarcinomaStatus unknownNCT02403544Phase 1
• Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric AdenocarcinomaCompletedNCT02370849Phase 2
• Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal CancerStatus unknownNCT02355249Phase 3
• Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung CancerCompletedNCT02323737Phase 2
• Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 TrialStatus unknownNCT02319187Phase 3
• Everolimus trIal for Advanced prememopausaL Breast Cancer PatientsStatus unknownNCT02313051Phase 2
• Observational Study on the Patients With Rectal CancerCompletedNCT02312284
• A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric AdenocarcinomaCompletedNCT02301481Phase 2
• A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric CancerStatus unknownNCT02296658Phase 2
• Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell LymphomaCompletedNCT02276248Phase 2
• Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived）Status unknownNCT02218437Phase 4
• Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum CancerStatus unknownNCT02195141Phase 2
• Phase 1 Trial of Chlorogenic Acid in Patients With Advanced CancerTerminatedNCT02136342Phase 1
• Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell CarcinomaCompletedNCT02133612Phase 2
• Endoscopic Screening on Esophageal CancerCompletedNCT02094105Not applicable
• Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast CancerStatus unknownNCT02041338Phase 2
• Study on Blood Glucose Variations in Tumor Patients Before and After Total Parenteral NutritionCompletedNCT02024321
• Postoperative Conformal Radiotherapy for Stage II-III B Type ThymomaStatus unknownNCT02014805Phase 3
• Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic AnemiaStatus unknownNCT01997372Phase 4
• Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic LeukemiaStatus unknownNCT01990807Phase 4
• First Line Chemotherapy for Advanced CancerTerminatedNCT01980810Phase 2
• Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung CancerStatus unknownNCT01969955Phase 2
• Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer PatientsStatus unknownNCT01939054Phase 2
• Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal CarcinomaStatus unknownNCT01930942Phase 2
• Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal CancerStatus unknownNCT01871363Phase 2
• The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI CancerStatus unknownNCT01863420
• Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional RegimenStatus unknownNCT01850147Phase 2
• The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRTStatus unknownNCT01817023Phase 3
• The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRTCompletedNCT01797900Phase 2
• Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction CancerStatus unknownNCT01747707Phase 2
• Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;Status unknownNCT01745107Phase 3
• Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal CancerStatus unknownNCT01679327Phase 2
• Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer PatientsStatus unknownNCT01674959Phase 2
• Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical CancerStatus unknownNCT01667211Phase 2

← Chinese Academy of Medical Sciences overview and focus areas